Skip to content
Clinical Trials – home
Research site

Medical Center Zdrave Lom EOOD

Bulgaria Ulitsa Panayot Volov 6, 3600 Lom, Bulgaria

  • 1 trial recruiting
  • Obesity · Overweight · Type 2 diabetes mellitus
  • Adult patients

About Specializations

Medical Center Zdrave Lom EOOD in Lom, Bulgaria specialises in clinical trials of conditions such as Obesity, Overweight, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Type 2 Diabetes

At Medical Center Zdrave Lom EOOD, researchers are investigating novel oral treatments for type 2 diabetes, aiming to improve blood‑sugar management in patients who remain uncontrolled on standard medication.

  • Comparison of new therapy versus existing GLP‑1 analogues
  • Impact on HbA1c reduction
  • Assessment of safety and tolerability
  • Potential benefits for weight reduction

The work contributes to advancing metabolic care and offers hope for better long‑term outcomes.

Overweight and Obesity

The site is also conducting studies on overweight and obesity, testing an oral agent combined with lifestyle changes to enhance weight loss in adults.

  • Evaluation of weight change with reduced‑calorie diet
  • Integration of increased physical activity
  • Safety profile of the oral medication
  • Improvement in metabolic health markers

These trials align with the centre’s focus on nutritional and metabolic diseases and aim to provide new options for weight management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ulitsa Panayot Volov 63600 LomBulgaria
Recruiting now
1 trial
Conditions studied
3

More sites in LomBulgaria

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Obesity+1

Recruiting
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.